|
Re: A Special Meeting of Shareholders?
|
5
|
Resverlogix Corp.
|
Jun 07, 2024 06:51AM
|
|
Re: Sales could take a hit
|
5
|
Resverlogix Corp.
|
Apr 17, 2023 12:43PM
|
|
Re: Resverlogix Announces Change in Fiscal Year-End to December 31
|
5
|
Resverlogix Corp.
|
Mar 14, 2021 11:02AM
|
|
Re: Thanks for the last two days posts!
|
5
|
Resverlogix Corp.
|
Oct 20, 2023 04:16PM
|
|
Re: Q1- March 31, 2022 on SEDAR
|
5
|
Resverlogix Corp.
|
May 14, 2022 07:48PM
|
|
Re: I think one major reason that,
|
5
|
Resverlogix Corp.
|
Nov 01, 2019 04:07PM
|
|
Re: I thought we'd have some news on the loan today....
|
5
|
Resverlogix Corp.
|
Sep 14, 2019 09:41PM
|
|
Re: RVX Status
|
5
|
Resverlogix Corp.
|
Nov 28, 2020 10:56AM
|
|
Re: RVX Status
|
5
|
Resverlogix Corp.
|
Nov 28, 2020 12:44PM
|
|
Re: Name 3 things this CEO has accomplished in the last 3 year's?
|
5
|
Resverlogix Corp.
|
Nov 29, 2023 08:19PM
|
|
Re: The MD@A for the period ending July 31, 2017
|
5
|
Resverlogix Corp.
|
Sep 15, 2017 08:50AM
|
|
Resverlogix Announces Commencement of Patient Enrollment and Dosing in a Phase 2b Trial for a Promising Canadian-Developed COVID-19 Treatment
|
5
|
Resverlogix Corp.
|
Jan 18, 2022 08:06AM
|
|
Resverlogix (RVX) Reports Fiscal Year 2017 Results
|
5
|
Resverlogix Corp.
|
Aug 15, 2017 07:14AM
|
|
Re: Leading From Behind
|
5
|
Resverlogix Corp.
|
Oct 14, 2020 10:38AM
|
|
Re: What's the deal?
|
5
|
Resverlogix Corp.
|
Nov 29, 2020 09:28AM
|
|
Re: Epizyme market cap $750 mil USd
|
5
|
Zenith Epigenetics
|
Jun 15, 2017 09:53PM
|
|
Re: Sneaking Suspicion...
|
5
|
Resverlogix Corp.
|
Feb 04, 2021 09:55PM
|
|
Re: RVX Announces Update Webcast and Conference Call
|
6
|
Resverlogix Corp.
|
Jan 18, 2021 01:52PM
|
|
Re: Debt and 28 August
|
6
|
Resverlogix Corp.
|
Jul 28, 2017 09:40AM
|
|
Re: Some history
|
6
|
Resverlogix Corp.
|
Jan 25, 2023 09:23AM
|
